博客 发表于 4月 4, 2021 Adoption of Point-of-Care testing services in diabetes and in the context of COVID-19 Adoption of point-of-care testing services in diabetes and in the context of COVID-19 en ja ShareLikeTweet Video Player is loading.Play VideoPlayMuteCurrent Time 0:00/Duration -:-Loaded: 0%0:00Stream Type LIVESeek to live, currently behind liveLIVERemaining Time --:- 1xPlayback Rate3x2x1.5x1.25x1x, selected0.75x0.5x0.25xChaptersChaptersDescriptionsdescriptions off, selectedSubtitlessubtitles settings, opens subtitles settings dialogsubtitles off, selectedPortuguês(Brasil)日本語Audio TrackFullscreenThis is a modal window.Beginning of dialog window. Escape will cancel and close the window.TextColorWhiteBlackRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentBackgroundColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentTransparentWindowColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyTransparentSemi-TransparentOpaqueFont Size50%75%100%125%150%175%200%300%400%Text Edge StyleNoneRaisedDepressedUniformDropshadowFont FamilyProportional Sans-SerifMonospace Sans-SerifProportional SerifMonospace SerifCasualScriptSmall CapsReset restore all settings to the default valuesDoneClose Modal DialogEnd of dialog window. 媒体错误 尝试加载媒体时出错。请稍后再试。 重试： 0s Retrying, please wait 再试一次 Captions available: Portuguese(Brazil), Japanese (日本語). The views and opinions presented are of the author only. The content contained in this podcast is intended for informational / educational purposes only. © 2024 年雅培。版权所有。引用的所有商标均为雅培集团公司或其各自所有者的商标。 相关新闻 卡片 博客 发表于 9月 13, 2023 The American Diabetes Association standards of care - 2023 guidelines provide recommendations for healthcare providers regarding cardiovascular disease (CVD) and risk management in people with diabetes. The authors highlight that atherosclerotic cardiovascular disease (ASCVD) and heart failure (HF) are leading causes of morbidity and mortality for people with diabetes, noting that simultaneously addressing cardiovascular (CV) risk factors can con... American Diabetes Association recommendations for cardiovascular disease in diabetes en 立即访问 博客 发表于 7月 28, 2023 The Kidney Disease: Improving Global Outcomes (KIDGO) 2022 clinical practice guidelines are based on a systematic review of evidence and aim to assist health care professionals with their decision making for people with diabetes and chronic kidney disease (CKD). The authors highlight that by 2045, 784 million people are estimated to have diabetes globally, of whom ≥40% will develop CKD, potentially leading to kidney failure requiring dialysis or ... KIDGO clinical practice guidelines: diabetes management in chronic kidney disease en 立即访问 受限 博客 发表于 7月 28, 2023 The objective of this longitudinal cohort study was to determine the prevalence of chronic kidney disease (CKD) and associated risk factors in a rural South African population. The authors note that infectious and non-communicable disease are a substantial risk for CKD in Africa, but that heterogeneity in assessment and diagnostic criteria hamper the interpretation of prevalence. Chronic kidney disease prevalence and risks in rural South Africa en 立即访问 受限 查看更多
